These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12241849)

  • 1. Activation of coagulation and fibrinolytic system and thrombotic tendency.
    van der Bom JG; Kluft C
    Lancet; 2002 Sep; 360(9335):801-2; author reply 802. PubMed ID: 12241849
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritability of clot formation.
    Standeven KF; Uitte de Willige S; Carter AM; Grant PJ
    Semin Thromb Hemost; 2009 Jul; 35(5):458-67. PubMed ID: 19739036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.
    Carmeliet P; Collen D
    Curr Opin Lipidol; 1997 Apr; 8(2):118-25. PubMed ID: 9183550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin monomers derived from thrombogenic dysfibrinogenemia, Naples-type variant (BβAla68Thr), showed almost entirely normal polymerization.
    Kamijo T; Nagata K; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2018 Dec; 172():1-3. PubMed ID: 30321757
    [No Abstract]   [Full Text] [Related]  

  • 8. The fibrinolytic system and haemostasis.
    Chesterman CN
    Thromb Diath Haemorrh; 1975 Nov; 34(2):368-77. PubMed ID: 53891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.
    Cellai AP; Lami D; Antonucci E; Fiorillo C; Becatti M; Olimpieri B; Bani D; Grifoni E; Cenci C; Marcucci R; Mannini L; Poli D; Abbate R; Prisco D
    Thromb Haemost; 2013 Mar; 109(3):565-7. PubMed ID: 23306795
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
    Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 16. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of blood coagulation and fibrinolysis.
    Patthy L
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):153-66. PubMed ID: 2130927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Differences in the Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury.
    Nakae R; Fujiki Y; Takayama Y; Kanaya T; Igarashi Y; Suzuki G; Naoe Y; Yokobori S
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.